Mining for mutations in malignant hyperthermia

Anesthesia and Analgesia

Volumn 113, Issue 5, 2011, Pages 975-976

  Rosenberg, Henry ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CAFFEINE; CALCIUM CHANNEL; DNA; DNA FRAGMENT; HALOTHANE; RYANODINE; SUXAMETHONIUM; VOLATILE AGENT;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; DNA DETERMINATION; DUCHENNE MUSCULAR DYSTROPHY; EDITORIAL; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; LABORATORY TEST; MALIGNANT HYPERTHERMIA; MORBIDITY; MORTALITY; MUSCLE BIOPSY; PHARMACOGENETICS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SICKLE CELL ANEMIA;

HUMANS; MALIGNANT HYPERTHERMIA;

EID: 80055068269     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31822dd4ca     Document Type: Editorial

References (7)

1. Dirksen SJH, Larach ML, Rosenberg H, Brandom BW, Parness J, Lang RS, Gangadharan M, Pezalski T. Future directions in malignant hyperthermia research and patient care. Anesth Analg 2011;113:1108-19
2. Rosero EB, Adesanya AO, Timaran CH, Joshi GP. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology 2009;110:89-94
3. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Wortont RG. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990;343:559-61
4. Broman M, Heinecke K, Islander G, Glahn K, Schuster F, Bodelsson M, Treves S, Muller C. Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high tesolution melt curve analysis. Anesth Analg 2011;113:1120-8
5. Sambuughin N, Holley H, Muldoon S, Brandom BW, de Bantel AM, Tobin JR, Nelson TE, Goldfarb LG. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population. Anesthesiology2005;102:515-21
6. Wilmshurst JM, Lillis S, Zhou H, Pillay K, Henderson H, Kress W, Muller CR, Ndondo A, Cloke V, Cullup T, Bertini E, Boennemann C, Straub V, Quinlivan R, Dowling JJ, Al-Sarraj S, Treves S, Abbs S, Manzur AY, Sewry CA, Muntoni F, Jungbluth H. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol2010;68:717-26
7. Capacchione JF, Sambuughin N, Bina S, Mulligan LP, Lawson TD, Muldoon SM. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms. Anesthesiology 2010;112: 239-44